Welcome Message

Welcome to the 6^th World Summit on Diabetes in Rome, May 19-20, 2025! We’re thrilled to explore cutting-edge research and advancements in diabetes care with leading experts. Rome's unique blend of history and modernity sets the stage for innovation and collaboration. We look forward to discovering new insights and making meaningful progress together. Thank you for joining us!

About The Conference:

The 6^th World Summit on Diabetes, taking place on May 19-20, 2025, in the magnificent city of Rome, Italy, is a pivotal event in advancing diabetes research and treatment. This premier conference will unite a global network of experts, researchers, and clinicians to delve into the latest innovations and strategies in diabetes care. Attendees will benefit from a rich program featuring cutting-edge keynote addresses, interactive workshops, and collaborative discussions designed to tackle the most pressing challenges in the field.

Set against Rome’s iconic backdrop, the DIABETES SUMMIT 2025 offers a unique blend of scientific inquiry and cultural enrichment. The city’s historic charm and vibrant atmosphere provide an inspiring setting for fostering new ideas and connections.

In addition to the enriching scientific agenda, attendees will have the opportunity to explore Rome’s world-renowned cultural landmarks, offering a perfect balance of professional and personal enrichment. The summit aims not only to advance diabetes management but also to celebrate the intersection of global expertise and local culture. We look forward to a transformative experience that drives forward the future of diabetes care and prevention, set in one of the world’s most captivating cities.

Session and tracks

Track 01: Pancreas and Diabetes

Diabetes arises when excess glucose accumulates in the bloodstream because the pancreas either fails to produce sufficient insulin or the body doesn’t use it effectively. Insulin is crucial for cells to absorb glucose. Once food is digested, glucose enters the blood, and without adequate insulin, energy levels drop.

Related Conferences:

American Diabetes Association (ADA) Annual Meeting | European Association for the Study of Diabetes (EASD) Annual Meeting | International Diabetes Federation (IDF) World Diabetes Congress | Diabetes UK Professional Conference | American Association of Clinical Endocrinologists (AACE) | Annual Scientific & Clinical Congress | International Conference on Diabetes and Metabolism | Global Diabetes Summit

Related Societies:

American Diabetes Association (ADA) | European Association for the Study of Diabetes (EASD) | International Diabetes Federation (IDF) | Diabetes UK | American Association of Clinical Endocrinologists (AACE) | Diabetes Technology Society (DTS) | Canadian Diabetes Association (CDA) | Asian Association for the Study of Diabetes (AASD)

Track 02: Pathophysiology and Causes

Diabetes is marked by persistently high blood glucose levels, or hyperglycemia, caused by irregularities in insulin production, action, or both. This condition can present in diverse ways, leading to disruptions in the metabolism of carbohydrates, fats, and proteins.

Related Conferences:

American Diabetes Association (ADA) Annual Meeting | European Association for the Study of Diabetes (EASD) Annual Meeting | International Diabetes Federation (IDF) World Diabetes Congress | Diabetes UK Professional Conference | American Association of Clinical Endocrinologists (AACE) | Annual Scientific & Clinical Congress | International Conference on Diabetes and Metabolism | Global Diabetes Summit

Related Societies:

American Diabetes Association (ADA) | European Association for the Study of Diabetes (EASD) | International Diabetes Federation (IDF) | Diabetes UK | American Association of Clinical Endocrinologists (AACE) | Diabetes Technology Society (DTS) | Canadian Diabetes Association (CDA) | Asian Association for the Study of Diabetes (AASD)

Track 03: Insulin

Insulin is a hormone produced by the pancreas that is crucial for your body to convert sugar (glucose) into energy. When the pancreas fails to produce sufficient insulin or when the body doesn’t effectively use it, blood sugar levels rise, resulting in diabetes.

Related Conferences:

American Diabetes Association (ADA) Annual Meeting | European Association for the Study of Diabetes (EASD) Annual Meeting | International Diabetes Federation (IDF) World Diabetes Congress | Diabetes UK Professional Conference | American Association of Clinical Endocrinologists (AACE) | Annual Scientific & Clinical Congress | International Conference on Diabetes and Metabolism | Global Diabetes Summit

Related Societies:

American Diabetes Association (ADA) | European Association for the Study of Diabetes (EASD) | International Diabetes Federation (IDF) | Diabetes UK | American Association of Clinical Endocrinologists (AACE) | Diabetes Technology Society (DTS) | Canadian Diabetes Association (CDA) | Asian Association for the Study of Diabetes (AASD)

Track 04: Antidiabetics

An antidiabetic drug is any medication designed to reduce elevated blood glucose levels, a hallmark of diabetes mellitus, a disorder of the endocrine system. Diabetes arises from the body's inability to either produce sufficient insulin or properly respond to it.

Related Conferences:

American Diabetes Association (ADA) Annual Meeting | European Association for the Study of Diabetes (EASD) Annual Meeting | International Diabetes Federation (IDF) World Diabetes Congress | Diabetes UK Professional Conference | American Association of Clinical Endocrinologists (AACE) | Annual Scientific & Clinical Congress | International Conference on Diabetes and Metabolism | Global Diabetes Summit

Related Societies:

American Diabetes Association (ADA) | European Association for the Study of Diabetes (EASD) | International Diabetes Federation (IDF) | Diabetes UK | American Association of Clinical Endocrinologists (AACE) | Diabetes Technology Society (DTS) | Canadian Diabetes Association (CDA) | Asian Association for the Study of Diabetes (AASD)

Track 05: Insulin & Beta-Cells

Beta cells, located in clusters called islets within the pancreas, are responsible for producing insulin, which regulates blood glucose levels. In type 1 diabetes, the immune system erroneously targets and destroys these insulin-producing beta cells.

Related Conferences:

American Diabetes Association (ADA) Annual Meeting | European Association for the Study of Diabetes (EASD) Annual Meeting | International Diabetes Federation (IDF) World Diabetes Congress | Diabetes UK Professional Conference | American Association of Clinical Endocrinologists (AACE) | Annual Scientific & Clinical Congress | International Conference on Diabetes and Metabolism | Global Diabetes Summit

Related Societies:

American Diabetes Association (ADA) | European Association for the Study of Diabetes (EASD) | International Diabetes Federation (IDF) | Diabetes UK | American Association of Clinical Endocrinologists (AACE) | Diabetes Technology Society (DTS) | Canadian Diabetes Association (CDA) | Asian Association for the Study of Diabetes (AASD)

Track 06: Types of Diabetes

• Type 1 Diabetes: An autoimmune condition where the immune system attacks and destroys insulin-producing beta cells in the pancreas, leading to little or no insulin production.
• Type 2 Diabetes: A metabolic disorder characterized by insulin resistance and a gradual decline in insulin production. It is often associated with obesity and lifestyle factors.
• Gestational Diabetes: Diabetes that occurs during pregnancy and usually disappears after childbirth. However, it increases the risk of developing type 2 diabetes later in life.

Related Conferences:

American Diabetes Association (ADA) Annual Meeting | European Association for the Study of Diabetes (EASD) Annual Meeting | International Diabetes Federation (IDF) World Diabetes Congress | Diabetes UK Professional Conference | American Association of Clinical Endocrinologists (AACE) | Annual Scientific & Clinical Congress | International Conference on Diabetes and Metabolism | Global Diabetes Summit

Related Societies:

American Diabetes Association (ADA) | European Association for the Study of Diabetes (EASD) | International Diabetes Federation (IDF) | Diabetes UK | American Association of Clinical Endocrinologists (AACE) | Diabetes Technology Society (DTS) | Canadian Diabetes Association (CDA) | Asian Association for the Study of Diabetes (AASD)

Track 07: Glycemic Disorder

Dysglycemia is a general term describing irregularities in blood sugar regulation. It encompasses both hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar). These conditions arise due to disruptions in insulin, a hormone produced by the pancreas that regulates blood glucose levels.

Related Conferences:

American Diabetes Association (ADA) Annual Meeting | European Association for the Study of Diabetes (EASD) Annual Meeting | International Diabetes Federation (IDF) World Diabetes Congress | Diabetes UK Professional Conference | American Association of Clinical Endocrinologists (AACE) | Annual Scientific & Clinical Congress | International Conference on Diabetes and Metabolism | Global Diabetes Summit

Related Societies:

American Diabetes Association (ADA) | European Association for the Study of Diabetes (EASD) | International Diabetes Federation (IDF) | Diabetes UK | American Association of Clinical Endocrinologists (AACE) | Diabetes Technology Society (DTS) | Canadian Diabetes Association (CDA) | Asian Association for the Study of Diabetes (AASD)

Track 08: Genetic Factors

Genetic factors play a significant role in the development of diabetes. Here are key aspects:

• Family History
• Genetic Mutations
• Genetic Syndromes
• Genetic Predisposition
• Monogenic Diabetes
• Epigenetics

Related Conferences:

American Diabetes Association (ADA) Annual Meeting | European Association for the Study of Diabetes (EASD) Annual Meeting | International Diabetes Federation (IDF) World Diabetes Congress | Diabetes UK Professional Conference | American Association of Clinical Endocrinologists (AACE) | Annual Scientific & Clinical Congress | International Conference on Diabetes and Metabolism | Global Diabetes Summit

Related Societies:

American Diabetes Association (ADA) | European Association for the Study of Diabetes (EASD) | International Diabetes Federation (IDF) | Diabetes UK | American Association of Clinical Endocrinologists (AACE) | Diabetes Technology Society (DTS) | Canadian Diabetes Association (CDA) | Asian Association for the Study of Diabetes (AASD)

Track 09: Hyperglycemic Dermatosis

Hyperglycemic Dermatosis refers to skin issues caused by prolonged high blood sugar levels in diabetes. Common conditions include diabetic dermopathy, necrobiosis lipoidica, acanthosis nigricans, and diabetic blisters. These skin changes are linked to chronic hyperglycemia and are managed by improving blood glucose control.

Related Conferences:

American Diabetes Association (ADA) Annual Meeting | European Association for the Study of Diabetes (EASD) Annual Meeting | International Diabetes Federation (IDF) World Diabetes Congress | Diabetes UK Professional Conference | American Association of Clinical Endocrinologists (AACE) | Annual Scientific & Clinical Congress | International Conference on Diabetes and Metabolism | Global Diabetes Summit

Related Societies:

American Diabetes Association (ADA) | European Association for the Study of Diabetes (EASD) | International Diabetes Federation (IDF) | Diabetes UK | American Association of Clinical Endocrinologists (AACE) | Diabetes Technology Society (DTS) | Canadian Diabetes Association (CDA) | Asian Association for the Study of Diabetes (AASD)

Track 10: Metabolic Kidney Disorder

Metabolic Kidney Disorder refers to kidney problems arising from metabolic imbalances, such as those seen in diabetes. These disorders can include conditions like diabetic nephropathy, where high blood glucose levels damage kidney function, leading to complications like proteinuria and impaired kidney function. Proper management of blood glucose and blood pressure is crucial for preventing or mitigating these issues.

Related Conferences:

American Diabetes Association (ADA) Annual Meeting | European Association for the Study of Diabetes (EASD) Annual Meeting | International Diabetes Federation (IDF) World Diabetes Congress | Diabetes UK Professional Conference | American Association of Clinical Endocrinologists (AACE) | Annual Scientific & Clinical Congress | International Conference on Diabetes and Metabolism | Global Diabetes Summit

Related Societies:

American Diabetes Association (ADA) | European Association for the Study of Diabetes (EASD) | International Diabetes Federation (IDF) | Diabetes UK | American Association of Clinical Endocrinologists (AACE) | Diabetes Technology Society (DTS) | Canadian Diabetes Association (CDA) | Asian Association for the Study of Diabetes (AASD)

Track 11: Diabetic Retinopathy

Diabetic Retinopathy is an eye condition caused by diabetes, where high blood sugar damages retinal blood vessels. It can lead to vision problems and blindness if untreated. Key stages include non-proliferative (early) and proliferative (advanced) retinopathy. Regular eye exams and good blood sugar control are essential for prevention and management.

Related Conferences:

American Diabetes Association (ADA) Annual Meeting | European Association for the Study of Diabetes (EASD) Annual Meeting | International Diabetes Federation (IDF) World Diabetes Congress | Diabetes UK Professional Conference | American Association of Clinical Endocrinologists (AACE) | Annual Scientific & Clinical Congress | International Conference on Diabetes and Metabolism | Global Diabetes Summit

Related Societies:

American Diabetes Association (ADA) | European Association for the Study of Diabetes (EASD) | International Diabetes Federation (IDF) | Diabetes UK | American Association of Clinical Endocrinologists (AACE) | Diabetes Technology Society (DTS) | Canadian Diabetes Association (CDA) | Asian Association for the Study of Diabetes (AASD)

Track 12: PCOS

In the context of diabetes, PCOS (Polycystic Ovary Syndrome) is a condition that can impact insulin resistance and glucose metabolism. Women with PCOS are at higher risk for:

• Insulin Resistance: Reduced effectiveness of insulin, leading to higher blood glucose levels.
• Type 2 Diabetes: Increased risk of developing type 2 diabetes due to metabolic disturbances.
• Obesity: Often associated with weight gain, which can exacerbate insulin resistance.

Management involves lifestyle changes, such as diet and exercise, along with medications that address both PCOS symptoms and insulin resistance.

Related Conferences:

American Diabetes Association (ADA) Annual Meeting | European Association for the Study of Diabetes (EASD) Annual Meeting | International Diabetes Federation (IDF) World Diabetes Congress | Diabetes UK Professional Conference | American Association of Clinical Endocrinologists (AACE) | Annual Scientific & Clinical Congress | International Conference on Diabetes and Metabolism | Global Diabetes Summit

Related Societies:

American Diabetes Association (ADA) | European Association for the Study of Diabetes (EASD) | International Diabetes Federation (IDF) | Diabetes UK | American Association of Clinical Endocrinologists (AACE) | Diabetes Technology Society (DTS) | Canadian Diabetes Association (CDA) | Asian Association for the Study of Diabetes (AASD)

Track 13: Pancreatic Dysfunction

Pancreatic Dysfunction is when the pancreas fails to produce enough insulin or digestive enzymes. In diabetes, it leads to poor blood glucose control and possible digestive issues. Treatment usually includes medication, lifestyle changes, and insulin therapy.

Related Conferences:

American Diabetes Association (ADA) Annual Meeting | European Association for the Study of Diabetes (EASD) Annual Meeting | International Diabetes Federation (IDF) World Diabetes Congress | Diabetes UK Professional Conference | American Association of Clinical Endocrinologists (AACE) | Annual Scientific & Clinical Congress | International Conference on Diabetes and Metabolism | Global Diabetes Summit

Related Societies:

American Diabetes Association (ADA) | European Association for the Study of Diabetes (EASD) | International Diabetes Federation (IDF) | Diabetes UK | American Association of Clinical Endocrinologists (AACE) | Diabetes Technology Society (DTS) | Canadian Diabetes Association (CDA) | Asian Association for the Study of Diabetes (AASD)

Track 14: Assessment & Tracking

Assessment & Tracking in diabetes involves monitoring blood glucose levels, evaluating treatment effectiveness, and identifying potential complications. Key methods include:

• Blood Glucose Monitoring: Regular checks to track daily glucose levels.
• HbA1c Testing: Measures average blood glucose over the past 2-3 months.
• Continuous Glucose Monitoring (CGM): Provides real-time glucose data.
• Health Assessments: Evaluations of overall health, including kidney function, eye exams, and foot checks.

These practices help manage diabetes effectively and adjust treatment plans as needed.

Related Conferences:

American Diabetes Association (ADA) Annual Meeting | European Association for the Study of Diabetes (EASD) Annual Meeting | International Diabetes Federation (IDF) World Diabetes Congress | Diabetes UK Professional Conference | American Association of Clinical Endocrinologists (AACE) | Annual Scientific & Clinical Congress | International Conference on Diabetes and Metabolism | Global Diabetes Summit

Related Societies:

American Diabetes Association (ADA) | European Association for the Study of Diabetes (EASD) | International Diabetes Federation (IDF) | Diabetes UK | American Association of Clinical Endocrinologists (AACE) | Diabetes Technology Society (DTS) | Canadian Diabetes Association (CDA) | Asian Association for the Study of Diabetes (AASD)

Track 15: Lifestyle Influences

Lifestyle Influences on diabetes involve several key factors: diet, which affects blood sugar levels; exercise, which improves insulin sensitivity; weight management, which impacts glucose control; stress, which can alter blood glucose; and sleep, which affects overall health. Effective management of these elements is crucial for maintaining optimal diabetes control and overall well-being.

Related Conferences:

American Diabetes Association (ADA) Annual Meeting | European Association for the Study of Diabetes (EASD) Annual Meeting | International Diabetes Federation (IDF) World Diabetes Congress | Diabetes UK Professional Conference | American Association of Clinical Endocrinologists (AACE) | Annual Scientific & Clinical Congress | International Conference on Diabetes and Metabolism | Global Diabetes Summit

Related Societies:

American Diabetes Association (ADA) | European Association for the Study of Diabetes (EASD) | International Diabetes Federation (IDF) | Diabetes UK | American Association of Clinical Endocrinologists (AACE) | Diabetes Technology Society (DTS) | Canadian Diabetes Association (CDA) | Asian Association for the Study of Diabetes (AASD)

Track 16: Diabetes-Related Surgery

Diabetes-Related Surgery encompasses various surgical procedures aimed at managing complications or improving diabetes control. Common types include:

• Bariatric Surgery: Weight-loss surgery that can improve insulin sensitivity and glycemic control.
• Pancreas Transplant: Replacing a damaged pancreas to restore insulin production.
• Islet Cell Transplant: Transplanting insulin-producing cells from a donor pancreas.
• Foot Surgery: Treating severe foot complications like ulcers or infections.

These surgeries are typically considered when other management strategies are insufficient.

Related Conferences:

American Diabetes Association (ADA) Annual Meeting | European Association for the Study of Diabetes (EASD) Annual Meeting | International Diabetes Federation (IDF) World Diabetes Congress | Diabetes UK Professional Conference | American Association of Clinical Endocrinologists (AACE) | Annual Scientific & Clinical Congress | International Conference on Diabetes and Metabolism | Global Diabetes Summit

Related Societies:

American Diabetes Association (ADA) | European Association for the Study of Diabetes (EASD) | International Diabetes Federation (IDF) | Diabetes UK | American Association of Clinical Endocrinologists (AACE) | Diabetes Technology Society (DTS) | Canadian Diabetes Association (CDA) | Asian Association for the Study of Diabetes (AASD)

Track 17: Endoscopic Procedures

Endoscopic Procedures involve using a flexible tube to diagnose or treat diabetes-related issues, such as gastroparesis or screening for colorectal problems. These minimally invasive methods assist in managing complications and assessing pancreatic function.

Related Conferences:

American Diabetes Association (ADA) Annual Meeting | European Association for the Study of Diabetes (EASD) Annual Meeting | International Diabetes Federation (IDF) World Diabetes Congress | Diabetes UK Professional Conference | American Association of Clinical Endocrinologists (AACE) | Annual Scientific & Clinical Congress | International Conference on Diabetes and Metabolism | Global Diabetes Summit

Related Societies:

American Diabetes Association (ADA) | European Association for the Study of Diabetes (EASD) | International Diabetes Federation (IDF) | Diabetes UK | American Association of Clinical Endocrinologists (AACE) | Diabetes Technology Society (DTS) | Canadian Diabetes Association (CDA) | Asian Association for the Study of Diabetes (AASD)

Track 18: Diabetes Complications

Diabetes Complications encompass cardiovascular disease, nerve damage (neuropathy), eye damage (retinopathy), kidney damage (nephropathy), and foot issues. These complications arise from prolonged high blood sugar levels. Effective management of blood glucose is essential to prevent or minimize these problems. Regular check-ups and lifestyle adjustments play a crucial role in mitigating risks.

Related Conferences:

American Diabetes Association (ADA) Annual Meeting | European Association for the Study of Diabetes (EASD) Annual Meeting | International Diabetes Federation (IDF) World Diabetes Congress | Diabetes UK Professional Conference | American Association of Clinical Endocrinologists (AACE) | Annual Scientific & Clinical Congress | International Conference on Diabetes and Metabolism | Global Diabetes Summit

Related Societies:

American Diabetes Association (ADA) | European Association for the Study of Diabetes (EASD) | International Diabetes Federation (IDF) | Diabetes UK | American Association of Clinical Endocrinologists (AACE) | Diabetes Technology Society (DTS) | Canadian Diabetes Association (CDA) | Asian Association for the Study of Diabetes (AASD)

Track 19: Psychosocial Aspects

Psychosocial Aspects of diabetes encompass the emotional impact, such as stress and depression, which can affect management and quality of life. Social support from family, friends, and support groups plays a vital role in managing diabetes. The condition also influences daily routines, work, and social interactions. Addressing these emotional and social factors is key to comprehensive diabetes care and improving overall well-being.

Related Conferences:

American Diabetes Association (ADA) Annual Meeting | European Association for the Study of Diabetes (EASD) Annual Meeting | International Diabetes Federation (IDF) World Diabetes Congress | Diabetes UK Professional Conference | American Association of Clinical Endocrinologists (AACE) | Annual Scientific & Clinical Congress | International Conference on Diabetes and Metabolism | Global Diabetes Summit

Related Societies:

American Diabetes Association (ADA) | European Association for the Study of Diabetes (EASD) | International Diabetes Federation (IDF) | Diabetes UK | American Association of Clinical Endocrinologists (AACE) | Diabetes Technology Society (DTS) | Canadian Diabetes Association (CDA) | Asian Association for the Study of Diabetes (AASD)

Track 20: AI in Diabetes

AI in Diabetes involves using artificial intelligence for predicting glucose levels, personalizing treatment, continuous monitoring, analyzing data, and providing support tools. It aims to enhance accuracy and efficiency in diabetes management.

Related Conferences:

American Diabetes Association (ADA) Annual Meeting | European Association for the Study of Diabetes (EASD) Annual Meeting | International Diabetes Federation (IDF) World Diabetes Congress | Diabetes UK Professional Conference | American Association of Clinical Endocrinologists (AACE) | Annual Scientific & Clinical Congress | International Conference on Diabetes and Metabolism | Global Diabetes Summit

Related Societies:

American Diabetes Association (ADA) | European Association for the Study of Diabetes (EASD) | International Diabetes Federation (IDF) | Diabetes UK | American Association of Clinical Endocrinologists (AACE) | Diabetes Technology Society (DTS) | Canadian Diabetes Association (CDA) | Asian Association for the Study of Diabetes (AASD)

Benefits of Participation

Benefits of Participation:

Conferences offer valuable opportunities for academic and business professionals, including:

• Presentations: Showcase your research to experts and influencers, fostering potential collaborations.
• Connect: Network with industry leaders and peers, especially valuable for young entrepreneurs.
• Excel: Gain knowledge and skills to advance in your field.
• Publication: Opportunity to publish your abstract or paper in the conference proceedings.
• Cooperation and Friendship: Engage with industry professionals and academics during meals and discussions.
• Skill Development: Enhance your skills through workshops and industry insights.
• Learn: Discover the latest advancements, new devices, and techniques from thought leaders.
• Exhibitions: Explore modern products on our dynamic exhibition floor.
• Value: Invest in your professional growth with lectures, workshops, and networking opportunities.
• Travel: Enjoy a break from routine, explore new cities, and meet new people, returning rejuvenated for your work.

Market Analysis

DIABETES SUMMIT 2025 will be a pivotal event in addressing the challenges and opportunities within the expanding Type 2 Diabetes market. This market is expected to grow by USD 42.6 billion at a CAGR of 10.84% from 2023 to 2028, driven by several key factors.

The rising prevalence of diabetes, coupled with increasing obesity rates and evolving lifestyles, significantly influences market growth. The growing incidence of diabetes is largely attributed to sedentary lifestyles and unhealthy dietary habits, which underscore the urgent need for innovative and effective diabetes management solutions. The concurrent rise in obesity rates, often associated with Type 2 Diabetes, further accelerates this market expansion. Additionally, changing lifestyles, marked by heightened stress and decreased physical activity, exacerbate the diabetes burden.

Recent product approvals also play a critical role in market dynamics, enhancing treatment options and contributing to market growth. The emphasis on advanced research and development is crucial for addressing these challenges.

DIABETES SUMMIT 2025 will serve as a vital platform for experts and stakeholders to discuss these trends and explore new solutions. The summit will facilitate valuable networking opportunities, foster collaboration, and provide insights into cutting-edge research and advancements in diabetes management. By aligning with the demand for innovative products and services, the summit aims to drive progress and improve outcomes in diabetes care.

Visa Trip Advisor

Planning a trip to Rome Italy? Attend our Meeting!

Issue with VISA?

To support participants in their VISA application process, we provide VISA support documents as follows:

1. Official Letter of Invitation

2. Official Letter of Abstract Acceptance

3. Receipt of Payment

Points to note:

• Visa Letter (official letter of invitation) will be issued only after successful registration and payment for the conference.
• Visa Letters can be issued only for the individual accepted to attend the conference.
• Please contact the Program Manager, Kyra Bennett, via contact@globalconferencemeet.com to arrange for a Visa Letter.

Kindly provide us with the following information for Visa Letters:

• Your name as it appears on your passport
• Passport Scan Copy (for passport number and date of birth)
• Abstract Acceptance letter for Presenters

Payment Methods:

1. Payment Gateway/RAZORPAY

2. Bank-to-Bank transfer

Having trouble with registration?

Please contact Program Manager Kyra Bennett, via contact@globalconferencemeet.com . The DIABETES SUMMIT 2025 team will provide you with an INVOICE for the requested price, enabling you to make the Bank-to-Bank transfer.